Acute toxicity of vitamin A given with vaccines in infancy

Area of Science:

• Pediatric Nutrition
• Public Health Interventions
• Clinical Toxicology

Background:

• Vitamin A is crucial for infant health and immune function.
• The Expanded Programme on Immunisation (EPI) provides a platform for delivering essential micronutrients.
• Understanding the safety profile of vitamin A supplementation in infants is vital for public health programs.

Purpose of the Study:

• To evaluate the safety and toxicity of vitamin A supplementation in infants.
• To assess adverse events associated with vitamin A administration within the EPI in rural Bangladesh.

Main Methods:

• A double-blind, randomized, placebo-controlled trial involving 191 infants.
• Infants received three doses of 50,000 IU vitamin A or placebo at approximately 1.5, 2.5, and 3.5 months.
• Post-supplementation monitoring for adverse events occurred on days 1, 2, 3, and 8.

Main Results:

• A significantly higher incidence of bulging fontanelle was observed in the vitamin A group (11.5%) compared to the placebo group (1%).
• 16 out of 17 reported events of bulging fontanelle occurred in infants receiving vitamin A.
• No other significant side effects were noted, but a trend towards cumulative toxicity with increasing doses was observed.

Conclusions:

• Vitamin A supplementation at 50,000 IU doses within the EPI in rural Bangladesh is associated with an increased risk of bulging fontanelle in infants.
• The findings suggest a potential cumulative toxicity effect, highlighting the need for careful dose evaluation in infant supplementation programs.
• Further research is recommended to optimize vitamin A dosing strategies to maximize benefits while minimizing potential risks in vulnerable infant populations.